Galleri Blood Test for Early Cancer Detection Fails in Crucial Study

A highly anticipated Galleri blood test, designed to detect over fifty types of cancer early, has failed to meet expectations in a decisive study, despite the underlying liquid biopsy principle still showing potential.

28 Feb, 04:30 — 28 Feb, 04:30

Post Share

ℹOnly 1 source covers this story

Read at source (1 outlet)

nzz3h ago

Das Ende eines Hypes: In der entscheidenden Studie versagt der Galleri-Bluttest zur Früherkennung von Krebs

Der Krebstest des Herstellers Grail sollte mehr als fünfzig verschiedene Tumoren erkennen und die Früherkennung revolutionieren. Die Realität sieht anders aus. Trotzdem hat das zugrunde liegende Prinzip der Flüssigbiopsie Potenzial.

Read full article →

PERSPECTA

PERSPECTA

Galleri Blood Test for Early Cancer Detection Fails in Crucial Study

Read at source (1 outlet)

Das Ende eines Hypes: In der entscheidenden Studie versagt der Galleri-Bluttest zur Früherkennung von Krebs

Related Stories

PhilHealth Expands Free Medicine Program to Quezon Province

Living with CTLA-4: A Rare Genetic Immune Disorder

Tragedy at “El. Venizelos”: Death of the 67-year-old under scrutiny and safety protocols for passengers with disabilities

Simulation Training Addresses Neonatal Respiratory Emergencies in India

PERSPECTA